CANF

Can-Fite BioPharma
CANF

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $50.7K invested in Can-Fite BioPharma in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

77% less capital invested

Capital invested by funds: $225K → $50.7K (-$174K)

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$26K
2
+$10K

Top Sellers

1
-$107K
2
-$26.1K
3
-$13K
4
AF
Advisornet Financial
Minnesota
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$26K
2
$13K
3
$11K
4
$698
5
–
6
–
7
–